| 31 March 2016 | Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes | Babiker, T; Vedovato, N; Patel, K; et al. |
| 7 February 2017 | Hyperglycaemia-related complications at the time of diagnosis can cause permanent neurological disability in children with neonatal diabetes | Day, JO; Flanagan, SE; Shepherd, MH; et al. |
| 2 April 2014 | GATA4 mutations are a cause of neonatal and childhood-onset diabetes | Shaw-Smith, C; De Franco, E; Lango Allen, H; et al. |
| 1 September 2016 | Prematurity should not prevent genetic testing for neonatal diabetes | Besser, RE; Flanagan, SE; Mackay, DG; et al. |
| 1 October 2016 | Monogenic autoimmune diseases of the endocrine system | Johnson, MB; Hattersley, AT; Flanagan, SE |
| 27 April 2016 | Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk. | Vedovato, N; Cliff, E; Proks, P; et al. |
| 3 May 2017 | Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts | De Franco, E; Flanagan, SE; Yagi, T; et al. |
| 9 June 2016 | Isolated pancreatic aplasia due to a hypomorphic PTF1A mutation | Houghton, JA; Swift, GH; Shaw-Smith, C; et al. |
| 5 April 2016 | Type 1 Diabetes Genetic Risk Score: a novel tool to discriminate monogenic and type 1 diabetes | Patel, KA; Oram, RA; Flanagan, SE; et al. |
| 11 April 2016 | Psychiatric morbidity in children with KCNJ11 neonatal diabetes | Bowman, P; Broadbridge, E; Knight, BA; et al. |
